Serial interferon-gamma release assays during treatment of active tuberculosis in young adults

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Lee, Sei Won ^a,b   Lee, Choon Taek ^b   Yim, Jae Joon ^c  

^a Armed Forces Capital Hospital   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ETHAMBUTOL; GAMMA INTERFERON; ISONIAZID; LEVOFLOXACIN; MOXIFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT; AGE; ARTICLE; FEVER; GAMMA INTERFERON RELEASE ASSAY; HOSPITAL ADMISSION; HUMAN; IMMUNOASSAY; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PATIENT MONITORING; PLEURA EFFUSION; PUBLIC HOSPITAL; SOLDIER; SOUTH KOREA; TREATMENT OUTCOME; TREATMENT RESPONSE; DRUG MONITORING; FOLLOW UP; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SECRETION; THORAX RADIOGRAPHY;

ADULT; ANTITUBERCULAR AGENTS; DRUG MONITORING; FOLLOW-UP STUDIES; HUMANS; IMMUNOASSAY; INTERFERON-GAMMA; MALE; MIDDLE AGED; MILITARY PERSONNEL; MYCOBACTERIUM TUBERCULOSIS; RADIOGRAPHY, THORACIC; REPUBLIC OF KOREA; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 77957913934     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-300     Document Type: Article

References (34)

1. Global tuberculosis control: surveillance, planning, financing. WHO report 2007. Geneva: World Health Organization.
2. Foulds J, O'Brien R. New tools for the diagnosis of tuberculosis: the perspective of developing countries. Int J Tuberc Lung Dis 1998, 2(10):778-783.
3. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007, 146(5):340-354.
4. Kang YA, Lee HW, Yoon HI, Cho B, Han SK, Shim YS, Yim JJ. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005, 293(22):2756-2761. 10.1001/jama.293.22.2756, 15941805.
5. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005, 54(RR-15):49-55.
6. Dheda K, Pooran A, Pai M, Miller RF, Lesley K, Booth HL, Scott GM, Akbar AN, Zumla A, Rook GA. Interpretation of Mycobacterium tuberculosis antigen-specific IFN-gamma release assays (T-SPOT.TB) and factors that may modulate test results. J Infect 2007, 55(2):169-173. 10.1016/j.jinf.2007.02.005, 17448540.
7. Pai M, Joshi R, Bandyopadhyay M, Narang P, Dogra S, Taksande B, Kalantri S. Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment. Infection 2007, 35(2):98-103. 10.1007/s15010-007-6114-z, 2951985, 17401714.
8. Aiken AM, Hill PC, Fox A, McAdam KP, Jackson-Sillah D, Lugos MD, Donkor SA, Adegbola RA, Brookes RH. Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Infect Dis 2006, 6:66. 10.1186/1471-2334-6-66, 1562425, 16573826.
9. Kobashi Y, Mouri K, Yagi S, Obase Y, Miyashita N, Oka M. Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment. J Infect 2009, 58(3):197-204. 10.1016/j.jinf.2008.08.009, 18848730.
10. Katiyar SK, Sampath A, Bihari S, Mamtani M, Kulkarni H. Use of the QuantiFERON-TB Gold In-Tube test to monitor treatment efficacy in active pulmonary tuberculosis. Int J Tuberc Lung Dis 2008, 12(10):1146-1152.
11. WHO Treatment of tuberculosis: guidelines for national programmes. 2003, 3, WHO.
12. Im JG, Itoh H, Lee KS, Han MC. CT-pathology correlation of pulmonary tuberculosis. Crit Rev Diagn Imaging 1995, 36(3):227-285.
13. Im JG, Itoh H, Shim YS, Lee JH, Ahn J, Han MC, Noma S. Pulmonary tuberculosis: CT findings--early active disease and sequential change with antituberculous therapy. Radiology 1993, 186(3):653-660.
14. Im JG, Webb WR, Han MC, Park JH. Apical opacity associated with pulmonary tuberculosis: high-resolution CT findings. Radiology 1991, 178(3):727-731.
15. Seung KJ, Bai GH, Kim SJ, Lew WJ, Park SK, Kim JY. The treatment of tuberculosis in South Korea. Int J Tuberc Lung Dis 2003, 7(10):912-919.
16. Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med 2000, 161(4 Pt 2):S221-247.
17. Kim HJ, Lee HJ, Kwon SY, Yoon HI, Chung HS, Lee CT, Han SK, Shim YS, Yim JJ. The prevalence of pulmonary parenchymal tuberculosis in patients with tuberculous pleuritis. Chest 2006, 129(5):1253-1258. 10.1378/chest.129.5.1253, 16685016.
18. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977, 33(1):159-174. 10.2307/2529310, 843571.
19. Carrara S, Vincenti D, Petrosillo N, Amicosante M, Girardi E, Goletti D. Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis 2004, 38(5):754-756. 10.1086/381754, 14986262.
20. Kobashi Y, Obase Y, Fukuda M, Yoshida K, Miyashita N, Oka M. Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacteriosis. Clin Infect Dis 2006, 43(12):1540-1546. 10.1086/509327, 17109285.
21. Kobashi Y, Sugiu T, Ohue Y, Mouri K, Obase Y, Miyashita N, Oka M. Long-term follow-up of the QuantiFERON TB-2G test for active tuberculosis disease. Intern Med 2008, 47(22):1957-1961. 10.2169/internalmedicine.47.1313, 19015607.
22. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 1993, 178(6):2243-2247. 10.1084/jem.178.6.2243, 2191280, 8245795.
23. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993, 178(6):2249-2254. 10.1084/jem.178.6.2249, 2191274, 7504064.
24. Apicella MA, Allen JC. A physiologic differentiation between delayed and immediate hypersensitivity. J Clin Invest 1969, 48(2):250-259. 10.1172/JCI105981, 322216, 4179171.
25. Leckie WJ, Tothill P. Albumin turnover in pleural effusions. Clin Sci 1965, 29(2):339-352.
26. Kang YA, Lee HW, Hwang SS, Um SW, Han SK, Shim YS, Yim JJ. Usefulness of whole-blood interferon-gamma assay and interferon-gamma enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis. Chest 2007, 132(3):959-965. 10.1378/chest.06-2805, 17505029.
27. Dewan PK, Grinsdale J, Kawamura LM. Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis. Clin Infect Dis 2007, 44(1):69-73. 10.1086/509928, 17143818.
28. Goletti D, Carrara S, Vincenti D, Saltini C, Rizzi EB, Schinina V, Ippolito G, Amicosante M, Girardi E. Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study. Clin Microbiol Infect 2006, 12(6):544-550. 10.1111/j.1469-0691.2006.01391.x, 16700703.
29. Lee JY, Choi HJ, Park IN, Hong SB, Oh YM, Lim CM, Lee SD, Koh Y, Kim WS, Kim DS, et al. Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J 2006, 28(1):24-30. 10.1183/09031936.06.00016906, 16611658.
30. Nishimura T, Hasegawa N, Mori M, Takebayashi T, Harada N, Higuchi K, Tasaka S, Ishizaka A. Accuracy of an interferon-gamma release assay to detect active pulmonary and extra-pulmonary tuberculosis. Int J Tuberc Lung Dis 2008, 12(3):269-274.
31. Vincenti D, Carrara S, Butera O, Bizzoni F, Casetti R, Girardi E, Goletti D. Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study. Clin Exp Immunol 2007, 150(1):91-98. 10.1111/j.1365-2249.2007.03462.x, 2219274, 17680823.
32. Kobashi Y, Mouri K, Yagi S, Obase Y, Miyashita N, Okimoto N, Matsushima T, Kageoka T, Oka M. Clinical utility of the QuantiFERON TB-2G test for elderly patients with active tuberculosis. Chest 2008, 133(5):1196-1202. 10.1378/chest.07-1995, 18263689.
33. Raby E, Moyo M, Devendra A, Banda J, De Haas P, Ayles H, Godfrey-Faussett P. The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis. PLoS One 2008, 3(6):e2489. 10.1371/journal.pone.0002489, 2409073, 18560573.
34. Lee SS, Chou KJ, Su IJ, Chen YS, Fang HC, Huang TS, Tsai HC, Wann SR, Lin HH, Liu YC. High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: Comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test. Infection 2009, 37(2):96-102. 10.1007/s15010-008-8082-3, 19139810.